Utilisation du fondaparinux 2,5 mg pour la prévention des évènements thromboemboliques veineux en médecine générale. ArchiMed Ville

The results of the ArchiMed study support that the thromboprophylaxis treatment with fondaparinux 2.5 mg in ambulatory general medicine, and the associated medical conditions were usually consistent with the SmPC or guidelines. However, a difference was found for the duration and the initial indication, in situations that may be regarded as presenting a risk by the prescriber.